Literature DB >> 9831576

High dose inhaled corticosteroids and dose dependent loss of diabetic control.

J L Faul1, W Tormey, V Tormey, C Burke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831576      PMCID: PMC58840          DOI: 10.1136/bmj.317.7171.1491

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Influence of adrenal cortical steroids on carbohydrate metabolism in man.

Authors:  J W CONN; S S FAJANS
Journal:  Metabolism       Date:  1956-03       Impact factor: 8.694

2.  Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.

Authors:  D J Clark; B J Lipworth
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

3.  Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus.

Authors:  R J Koenig; C M Peterson; R L Jones; C Saudek; M Lehrman; A Cerami
Journal:  N Engl J Med       Date:  1976-08-19       Impact factor: 91.245

4.  Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects.

Authors:  Y T Kruszynska; M Greenstone; P D Home; N J Cooke
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

Review 5.  Inhaled glucocorticoids for asthma.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  1995-03-30       Impact factor: 91.245

  5 in total
  8 in total

1.  Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.

Authors:  T W Harrison; A Wisniewski; J Honour; A E Tattersfield
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

2.  Inhaled corticosteroids and the risk of diabetes among the elderly.

Authors:  Nandini Dendukuri; Lucie Blais; Jacques LeLorier
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

3.  Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease.

Authors:  S D Singh; C Whale; N Houghton; P Daley-Yates; S M Kirby; A A Woodcock
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

4.  Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.

Authors:  David Blackburn; Janet Hux; Muhammad Mamdani
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

Review 5.  Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions.

Authors:  Muhammad Amin; Naeti Suksomboon
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

6.  The effect of an inhaled corticosteroid on glucose control in type 2 diabetes.

Authors:  John L Faul; Sandra R Wilson; James W Chu; James Canfield; Ware G Kuschner
Journal:  Clin Med Res       Date:  2009-02-26

7.  Effect of inhaled corticosteroids on glycemic status.

Authors:  Francis Egbuonu; Farrah A Antonio; Mahamood Edavalath
Journal:  Open Respir Med J       Date:  2014-01-31

8.  The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.

Authors:  Susan C Edwards; Sian E Fairbrother; Anna Scowcroft; Gavin Chiu; Andrew Ternouth; Brian J Lipworth
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-11-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.